Methamphetamine & Other Illicit Drugs
The ALGA Methamphetamine & Other Illicit Drugs interest group has been established to provide a platform for interested and related professionals to progress and highlight the issue of methamphetamine and other illicit drugs and the wide range of implications which these drugs have on human health and the environment.
Some of the key focuses of the group are to:
- Advocate for regulatory reform related to the assessment and management of illicit drugs and their impacts on human health and the built environment;
- Develop existing and new professional networks to build knowledge and capacity within industry for the appropriate and risk based assessment of sites impacted by illicit drug related activity.
- Build knowledge and capacity within industry to support the appropriate decontamination and remediation of sites impacted by illicit drug related activity.
- Advocate for, and support appropriate academic research into the impacts of illicit drug on human health and the built environment, to scientific and professional knowledge and understanding of illicit drug contamination risks.
- Provide as a reference point for up-to-date scientific knowledge and information on illicit drug impacts and human health risk in the built environment to inform opinion and reporting within the media.
*interested in sponsorship of this group?
- see here for details or contact firstname.lastname@example.org
Current Steering Committee Members (renewed each calendar year):
Miles Stratford, MethSolutions (Co-Chair)
Miles is the founder of MethSolutions, a full service MethRisk Management business helping businesses and individuals avoid and manage the risks presented by MethAffected property. Miles has been involved in the MethRisk Management business for over 7 years. He is a foundation member of the Auckland Regional Meth Working Group (ARMWG). He is also a member of the Standards NZ committee developing NZS 8150 – testing and decontamination of methamphetamine contaminated properties. Miles believes that the industries which serve the needs of people who find themselves dealing with meth affected properties, need to be better coordinated and improved. The harm that meth-affected-properties cause people, needs to be reduced. His view is that the Methamphetamine and Other Illicit Drugs Interest Group, operating under the ALGA framework, has a great opportunity to catalyse and promote positive development and change.
Dr Jackie Wright, Principal – Environmental Risk Sciences (Co-Chair)
Dr Jackie Wright has completed PhD research work through Flinders University, is the director of Environmental Risk Sciences and is a Fellow of ACTRA. She has over 25 years of experience in human health and environmental toxicology and risk assessment. She has been directly involved in the development of national guidelines for a wide range of issues.
Jonathon Angell, Business Unit Manager – Eurofins
Jonathon has more than 12 years’ experience in the environmental testing sector and has been involved in the clandestine drug testing industry since 2016. Jonathon coordinates a specialist environmental laboratory operation in Brisbane with a key focus on high end organic chemistry analysis including Methamphetamine and associated precursor compounds. Through the application of cutting edge analytical technologies, further supported by an industry leading technical department, Jonathon leads the development of new analytical practices for the collection and analysis of clandestine based residues and contaminants amongst other environmental and human health based challenges facing our industry.
Ian Brookman, Manager Business Strategy – Ventia
Ian has nearly 20 years’ experience in the assessment, management and remediation of contaminated land in Australia, New Zealand and the UK. Ian started his career as an environmental consultant and after 11 years moved across to Ventia (formerly Thiess) to focus on remediation service delivery for complex contaminated sites. Ian is interested in the practicalities of brownfield land remediation and urban renewal and has a keen focus on the evolution of the contaminated land sector in Australia. Ian has been a Director on the ALGA Board for the past three years and has also been the President of the Association for the past two years. In 2011, Ian became the Victorian Committee Chair for ALGA, where he was responsible for developing, coordinating and hosting many successful forums. Ian held this role for 2.5 years. Ian was also the ACLCA/ALGA coordinator in 2011, and the ISR Remediation Contractors’ Representative in 2013.
Graham Corban, Client Service Manager – Hill Laboratories
Graham has more than 25 years’ experience in the New Zealand environmental testing sector and has been involved in methamphetamine testing industry since 2012. He is a specialist in methamphetamine laboratory analysis, with an in-depth knowledge of state-of-the-art analytical techniques for the detection of methamphetamine in properties for investigative and remediation purposes. As a Client Service Manager for Hill Laboratories, he is a key technical point of contact for the methamphetamine testing industry and is a member of the Standards New Zealand committee developing NZS 8510 – testing and decontamination of methamphetamine-contaminated properties.
Hannah Crisp, Team Leader – ChemCentre
Hannah has more than 12 years’ experience in clandestine laboratory and illicit drug analysis and has attended over 300 clandestine laboratory scenes during this time. She manages a team of scientists who specialise in the attendance and analysis of clandestine laboratories in Western Australia (WA) as well as the analysis and reporting of routine illicit drug exhibits, drug profiling samples and clandestine remediation samples.
She was a working group member for the production of national training guidelines for clandestine laboratory attendance and is heavily involved with the running of training courses in conjunction with WA Police to ensure that all staff who attended clandestine laboratories in WA are suitably trained to enable these scenes to be processed as safely and efficiently as possible.
Paul Newell, FRACI CCHEM
Paul Newell is a forensic chemist and environmental scientist and Fellow of the Royal Australian Chemical Institute, holding tertiary qualifications in chemistry, environmental science as well as qualifications in forensic and clandestine drug laboratory investigation and has worked extensively in both the public and private sectors for more than 25 years.
Paul is a nationally and internationally recognised expert in the field of clandestine drug manufacture and site remediation, as well as in the management and disposal of chemicals and waste from illicit drug manufacture. Paul is the principal author of the Australian national guideline for the remediation of clandestine drug laboratory sites, and an author and co-author of ‘United Nations Office on Drugs and Crime’ (UNODC) guidelines including guidelines for disposal of chemicals from illicit drug manufacture (UNODC, 2017), and guideline for the safe handling and disposal of chemicals from illicit drug manufacture (UNODC, 2011), and is a contributing author to the Western Australia guidelines for assessment and risk management of clandestine drug laboratories.
Paul’s specialist knowledge and hands on experience in forensic chemistry, illicit drug manufacture and the associated public health and environmental impacts stem primarily from his former role as a forensic chemist and intelligence coordinator, having previously worked in Australian Commonwealth law enforcement specifically in the fields of illicit drug manufacture, illicit drug intelligence and precursor diversion, including providing training to State Police units within Australia.
Any enquiries can be directed to ALGA via email@example.com